Absence of early platelet increment in healthy mice during decitabine treatment.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 12 2022
Historique:
received: 14 06 2022
accepted: 20 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 28 12 2022
Statut: epublish

Résumé

Treatment of myelodysplastic syndromes includes the administration of the hypomethylating agent decitabine. An early platelet response in decitabine-treated myelodysplastic syndrome patients is a predictor of overall survival. The effect of decitabine on megakaryocytes and the bone marrow, however, is understudied. We show that an early platelet increment was not detectable in healthy mice during decitabine treatment. Analyses of bone marrow sections revealed vessels with dilated lumina, decreased cellularity, but increased number of red blood cells and the presence of (pro)platelet-like particles. Taken together, decitabine treatment of healthy mice does not induce an early platelet increment, but affects the bone marrow.

Identifiants

pubmed: 36564544
doi: 10.1038/s41598-022-26821-8
pii: 10.1038/s41598-022-26821-8
pmc: PMC9789030
doi:

Substances chimiques

Decitabine 776B62CQ27
Azacitidine M801H13NRU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22266

Informations de copyright

© 2022. The Author(s).

Références

Arch Histol Cytol. 2003 May;66(2):123-43
pubmed: 12846553
Blood Rev. 2013 Sep;27(5):243-59
pubmed: 23954262
Expert Rev Hematol. 2013 Oct;6(5):611-24
pubmed: 24094045
Thromb Haemost. 2011 Aug;106(2):337-43
pubmed: 21713321
Epigenetics. 2006 Jan-Mar;1(1):7-13
pubmed: 17998812
Nat Rev Cancer. 2012 Dec;12(12):849-59
pubmed: 23175121
Int J Cancer. 2008 Jul 1;123(1):8-13
pubmed: 18425818
Oncol Lett. 2016 Apr;11(4):2347-2352
pubmed: 27073478
Br J Haematol. 2020 Jun;189(5):e194-e197
pubmed: 32207144
Oncotarget. 2015 Jun 30;6(18):16653-62
pubmed: 25938546
J Clin Oncol. 2011 May 20;29(15):1987-96
pubmed: 21483003
Br J Haematol. 2011 Dec;155(5):599-606
pubmed: 21981697
N Engl J Med. 2020 Oct 1;383(14):1358-1374
pubmed: 32997910
Thromb Haemost. 2015 May;113(5):1021-34
pubmed: 25566808
Br J Haematol. 2014 Oct;167(1):62-8
pubmed: 24995683

Auteurs

Juliane Baumann (J)

Institute of Experimental Biomedicine - Chair I, University Hospital Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.

Markus Spindler (M)

Institute of Experimental Biomedicine - Chair I, University Hospital Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.

Yannick Throm (Y)

Institute of Experimental Biomedicine - Chair I, University Hospital Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.

Michael Lübbert (M)

Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
German Consortium for Translational Cancer Research, Freiburg, Germany.

Markus Bender (M)

Institute of Experimental Biomedicine - Chair I, University Hospital Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany. Bender_M1@ukw.de.

Articles similaires

1.00
Humans Yoga Low Back Pain Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH